Medarex Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 488

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

  • Investments
  • 4

Medarex General Information

Description

Operator of a biopharmaceutical company intended to focus on developing human antibody-based therapeutics to treat life-threatening and debilitating diseases. The company specializes in discovering, developing, and commercializing human antibody-based therapeutic products for cancer, inflammation, autoimmune, and infectious diseases.

Contact Information

Website
www.medarex.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 707 State Road
  • Princeton, NJ 08540
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 707 State Road
  • Princeton, NJ 08540
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medarex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medarex‘s full profile, request access.

Request a free trial

Medarex Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medarex Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Medarex‘s full profile, request access.

Request a free trial

Medarex Investments & Acquisitions (4)

Medarex’s most recent deal was a Later Stage VC with EOS Biotechnology for . The deal was made on 28-Sep-2000.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
EOS Biotechnology 28-Sep-2000 Later Stage VC Biotechnology
Genmab 13-Jun-2000 Early Stage VC Biotechnology
GenPharm International 01-Oct-1997 Merger/Acquisition Biotechnology
Northwest Biotherapeutics Corporate Drug Discovery
To view Medarex’s complete investments and acquisitions history, request access »

Medarex Exits (2)

Medarex’s most recent exit was on 28-Sep-2000 from EOS Biotechnology. The exit was categorized as with 10 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
EOS Biotechnology 28-Sep-2000 Completed
  • 10 buyers
Northwest Biotherapeutics Corporate Completed
  • 4 buyers
To view Medarex’s complete exits history, request access »

Medarex FAQs

  • When was Medarex founded?

    Medarex was founded in 1987.

  • Where is Medarex headquartered?

    Medarex is headquartered in Princeton, NJ.

  • What is the size of Medarex?

    Medarex has 488 total employees.

  • What industry is Medarex in?

    Medarex’s primary industry is Biotechnology.

  • Is Medarex a private or public company?

    Medarex is a Private company.

  • What is the current valuation of Medarex?

    The current valuation of Medarex is .

  • What is Medarex’s current revenue?

    The current revenue for Medarex is .

  • How much funding has Medarex raised over time?

    Medarex has raised $118M.

  • Who are Medarex’s investors?

    Bay City Capital, GreenHills Ventures, and Social Venture Circle have invested in Medarex.

  • When was Medarex acquired?

    Medarex was acquired on 01-Sep-2009.

  • Who acquired Medarex?

    Medarex was acquired by Bristol-Myers Squibb.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process